Fluorescent Probe for Assessment of Renal Elimination
Starting soon · Phase 4
Conditions studied: Augmented Renal Clearance, Critical Illness
In brief
Accurate measures of kidney function is important for precision dosing of many medications. The current methods of determining kidney function largely hinge on the use of equations that use common laboratory values such as serum creatinine \& static variables like age \& weight. These are helpful for trending over time, but often are inaccurate during times of medical illness. Other more accurate methods of measuring kidney function include urine collection, although this is not commonly used because of various reasons that make the collection inconvenient or unreliable. The new transdermal glomerular filtration (tGFR) device permits accurate, real-time evaluation of kidney function. This novel method has not been rigorously compared with urine collection \& other methods of determining kidney function in hospitalized patients. The goal of the study is to compare tGFR with other accepted methods of determining kidney function.
Key facts
- Study ID
- NCT07643467
- Run by
- Aaron Cook
- People needed
- 200
- Starts
- 2026-07-01
- Expected to finish
- 2028-06-30
- Last updated by the study team
- 2026-06-16
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18-65 years old
- critically ill or acutely ill hospitalized patients admitted to the intensive care unit
- Stable/normal renal function
You may not qualify if…
- Prisoners
- Pregnant women
- Laboratory evidence of unstable kidney function (KDIGO AKI stage 1-3--This includes subjects with Scr > 1.5x baseline)
Where it is running
- UKHealthCare/University of Kentucky — Lexington, Kentucky, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.